On the other hand, an animal-based study, in which the GLP-1R antagonist exendin-9 (Ex-9) was delivered into the fourth ventricle of hepatoma tumor-bearing rats, showed that it attenuated the cancer anorexia-cachexia syndrome. The gene discussed is GLP1R; the disease is neoplasm.